Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where William Lawrence is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 7 Completed
-
Inactivation of aerosolized SARS-CoV-2 by Pisharodi devices
Lawrence, W. (PI)
South Texas Neurosurgery Associates ( Award # )
3/1/22 → 9/1/22
Project: Research project
-
Teixobactin Development for Anthrax
Lawrence, W. (PI)
NovoBiotic Pharmaceuticals, LLC ( Award #5R44AI15265702)
7/28/21 → 6/30/22
Project: Research project
-
Air Purification of Airborne SARS-CoV-2 by Genesis Air Technology
Lawrence, W. (PI)
4/1/21 → 7/31/21
Project: Research project
-
Aerus ActivePure Air Purifier Against Respiratory Pathogens
Lawrence, W. (PI)
Aerus Medical, LLC ( Award # )
3/1/21 → 5/31/21
Project: Research project
-
Light-activated Compound Against Aerosolized SARS2
Lawrence, W. (PI)
2/1/21 → 5/1/21
Project: Research project
-
Advanced photohydrolysis technology demonstrates rapid inactivation of aerosolized SARS-CoV-2 and efficacy against other respiratory viral pathogens
Peel, J. E., Jardinella, E., Qu, Y., Plante, J. A., Mitchell, B. M., Walker, J. L., Garofalo, R. P., Weaver, S. C., Plante, K. S., Brasel, T. & Lawrence, W. S., Jun 2025, In: American Journal of Infection Control. 53, 6, p. 726-728 3 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Letter to the editor on “Advanced photohydrolysis technology demonstrates rapid inactivation of aerosolized SARS-CoV-2 and efficacy against other respiratory viral pathogens”
Peel, J. E. & Lawrence, W. S., Jun 2025, In: American Journal of Infection Control. 53, 6, p. 740-741 2 p.Research output: Contribution to journal › Letter › peer-review
-
Teixobactin: A Resistance-Evading Antibiotic for Treating Anthrax
Lawrence, W. S., Peel, J. E., de Winter, R., Ling, L. L., Nitti, A. G., Peoples, A. J., Shukla, R., MacGillavry, H. D., Heine, H. S., Hensel, M. E., Whorton, E. B., Weingarth, M., Lewis, K. & Hughes, D. E., Mar 14 2025, In: ACS Infectious Diseases. 11, 3, p. 727-737 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A bacteriophage cocktail targeting Yersinia pestis provides strong post-exposure protection in a rat pneumonic plague model
Kilgore, P. B., Sha, J., Hendrix, E. K., Neil, B. H., Lawrence, W. S., Peel, J. E., Hittle, L., Woolston, J., Sulakvelidze, A., Schwartz, J. A. & Chopra, A. K., Nov 2024, In: Microbiology Spectrum. 12, 11, e00942-24.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model
Lawrence, W. S., Peel, J. E., Slayden, R. A., Peterson, J. W., Baze, W. B., Hensel, M. E., Whorton, E. B., Beasley, D. W. C., Cummings, J. E. & Macias-Perez, I., Jul 9 2024, In: Antimicrobial agents and chemotherapy. 68, 7, p. e0011224Research output: Contribution to journal › Article › peer-review
Open Access